FDA notifications. Abacavir tablet approved for pediatric patients.
D002648:Child; D015224:Dideoxynucleosides / Q000627:therapeutic use*; D017277:Drug Approval / Q000331:legislation & jurisprudence*; D006801:Humans; D010372:Pediatrics; D018894:Reverse Transcriptase Inhibitors / Q000627:therapeutic use*; D013607:Tablets; D014481:United States; D014486:United States Food and Drug Administration; D000099227:Abacavir
D015224:Dideoxynucleosides; D018894:Reverse Transcriptase Inhibitors; D013607:Tablets; D000099227:Abacavir